Determinants of Acquisition, Persistence, and Clearance of Oncogenic Cervical Human Papillomavirus Infection in the Philippines Using a Multi-Omics Approach: DEFEAT HPV Study Protocol
-
Published:2023-02-23
Issue:5
Volume:11
Page:658
-
ISSN:2227-9032
-
Container-title:Healthcare
-
language:en
-
Short-container-title:Healthcare
Author:
de Paz-Silava Sheriah Laine M.12, Tabios Ian Kim B.134ORCID, Tantengco Ourlad Alzeus G.156ORCID, Climacosa Fresthel Monica M.12, Velayo Clarissa L.157ORCID, Lintao Ryan C. V.1ORCID, Cando Leslie Faye T.1ORCID, Perias Glenmarie Angelica S.1ORCID, Idolor Maria Isabel C.1, Francisco Abialbon G.12, Catral Charlene Divine M.1ORCID, Chiong Charlotte M.18, Dalmacio Leslie Michele M.13
Affiliation:
1. Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines 2. Department of Medical Microbiology, College of Public Health, University of the Philippines Manila, Manila 1000, Philippines 3. Department of Biochemistry and Molecular Biology, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines 4. Institute of Biology, College of Science, University of the Philippines Diliman, Quezon City 1101, Philippines 5. Department of Physiology, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines 6. Department of Biology, College of Science, De La Salle University, Manila 0922, Philippines 7. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of the Philippines College of Medicine—Philippine General Hospital, University of the Philippines Manila, Manila 1000, Philippines 8. Department of Otolaryngology—Head and Neck Surgery, University of the Philippines College of Medicine—Philippine General Hospital, Manila 1000, Philippines
Abstract
HPV infection is one of the most studied risk factors in cervical cancer—the second most common cancer site and cause of death due to cancer in the Philippines. However, there is a lack of population-based epidemiological data on cervical HPV infection in the Philippines. Local reports on co-infections with other lower genital tract pathogens, commonly reported globally, are also lacking, which emphasizes the need to increase efforts in targeting HPV prevalence, genotype, and distribution. Hence, we aim to determine the molecular epidemiology and natural history of HPV infection among reproductive-age Filipino women using a community-based prospective cohort design. Women from rural and urban centers will be screened until the target sample size of 110 HPV-positive women (55 from rural sites and 55 from urban sites) is reached. Cervical and vaginal swabs will be collected from all screened participants. For HPV-positive patients, HPV genotypes will be determined. One hundred ten healthy controls will be selected from previously screened volunteers. The cases and controls will comprise the multi-omics subset of participants and will be followed up after 6 and 12 months for repeat HPV screening. Metagenomic and metabolomic analyses of the vaginal swabs will also be performed at baseline, after 6 months, and after 12 months. The results of this study will update the prevalence and genotypic distribution of cervical HPV infection among Filipino women, determine whether the current vaccines used for HPV vaccination programs capture the most prevalent high-risk HPV genotypes in the country, and identify vaginal community state types and bacterial taxa associated with the natural history of cervical HPV infection. The results of this study will be used as the basis for developing a biomarker that can help predict the risk of developing persistent cervical HPV infection in Filipino women.
Funder
Department of Science and Technology—Philippine Council for Health Research and Development
Subject
Health Information Management,Health Informatics,Health Policy,Leadership and Management
Reference74 articles.
1. Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J., Gomez, D., Munoz, J., Bosch, F.X., and de Sanjose, S. (2021). Human Papillomavirus and Related Diseases in the World. Summary Report 22 October 2021, ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2. Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J., Gómez, D., Muñoz, J., Bosch, F., and de Sanjosé, S. (2021). Human Papillomavirus and Related Diseases in United States of America. Summary Report 22 October 2021, ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 3. Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gomez, D., Muñoz, J., Bosch, F.X., and de Sanjosé, S. (2021). Human Papillomavirus and Related Diseases in China. Summary Report 22 October 2021, ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 4. Five-Year Relative Survival for Human Papillomavirus-Associated Cancer Sites;Razzaghi;Cancer,2018 5. Cancer Statistics Working Group U.S. (2022, October 01). Cancer Statistics Data Visualizations Tool, Based on 2021 Submission Data (1999–2019): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Available online: https://www.cdc.gov/cancer/uscs/dataviz/index.htm.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|